Your session is about to expire
← Back to Search
Mesenchymal stem cells for Crohn's Disease
Study Summary
This trial will test if injecting stem cells into fistulas can heal them. 10 patients aged 13-17 will be treated at baseline and again 3 months later if needed.
- Crohn's Disease Perianal Fistula
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
Is the upper age limit for entry into this experiment above sixty years?
"This trial stipulates that only those between 13 and 17 years of age can participate. There are 321 trials for minors, while 899 studies cater to individuals aged over 65."
What is the aggregate count of participants engaged in this clinical trial?
"Absolutely. The information posted on clinicaltrials.gov affirms that recruitment is ongoing for this medical trial, initially listed on April 1st 2021 and most recently updated a year later. 10 patients are needed from one particular site."
Who qualifies to participate in this experiment?
"This study seeks out 10 patients with a particular disease between the ages of 13 and 17. Applicants must have single or multiple-tract perianal fistula, be able to employ contraception or abstinence during the trial, not suffer from claustrophobia nor have any contraindications for MRI evaluations (e.g., pacemaker)."
Is there still time to enroll in this experiment?
"Affirmative. Clinicaltrials.gov hosts the information that this medical trial is actively seeking patients, with 10 participants required from a single site since it was initially posted on April 1st 2021 and most recently updated again on April 1st 2022."
What is the current regulatory standing of Mesenchymal stem cells?
"Due to the limited data available for Mesenchymal stem cells, we have cautiously rated their safety a 1 on our scale."
Share this study with friends
Copy Link
Messenger